Schizophrenia Research
Volume 84, Issue 2 , Pages 214-221 , June 2006

N-methyl-d-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: Polymorphisms and mRNA levels

Received 8 August 2005 ,Revised 31 January 2006 ,Accepted 2 February 2006.

References 

  1. Akbarian S, Sucher NJ, et al. Selective alterations in gene expression for NMDA receptor subunits in prefrontal cortex of schizophrenics. J. Neurosci. 1996;16(1):19–30
  2. American Psychiatric Association A. Diagnostic and Statistical Manual of Mental Disorders. fourth edition. Washington, DC: American Psychiatric Association; 1994;
  3. Aoki C, Bredt DS, et al. The subcellular distribution of nitric oxide synthase relative to the NR1 subunit of NMDA receptors in the cerebral cortex. Prog. Brain Res. 1998;118:83–97
  4. Badner JA, Gershon ES. Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol. Psychiatry. 2002;7(4):405–411
  5. Benes FM, Todtenkopf MS, et al. GluR5,6,7 subunit immunoreactivity on apical pyramidal cell dendrites in hippocampus of schizophrenics and manic depressives. Hippocampus. 2001;11(5):482–491
  6. Chiu HJ, Wang YC, et al. Association analysis of the genetic variants of the N-methyl d-aspartate receptor subunit 2b (NR2b) and treatment-refractory schizophrenia in the Chinese. Neuropsychobiology. 2003;47(4):178–181
  7. Cull-Candy S, Brickley S, et al. NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 2001;11(3):327–335
  8. Dixon DA, Fenix LA, et al. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: I. Adenosine agonists. Ann. Pharmacother. 1999;33(4):480–488
  9. Gao XM, Sakai K, et al. Ionotropic glutamate receptors and expression of N-methyl-d-aspartate receptor subunits in subregions of human hippocampus: effects of schizophrenia. Am. J. Psychiatry. 2000;157(7):1141–1149
  10. Grimwood S, Slater P, et al. NR2B-containing NMDA receptors are up-regulated in temporal cortex in schizophrenia. NeuroReport. 1999;10(3):461–465
  11. Hedges LV, Olkin I, et al. In: Statistical Methods for Meta-Analysis. London: Academic Press; 1985;p. 39
  12. Henson J, Saffer J, et al. The transcription factor Sp1 binds to the JC virus promoter and is selectively expressed in glial cells in human brain. Ann. Neurol. 1992;32(1):72–77
  13. Hokin LE, Dixon JF, et al. A novel action of lithium: stimulation of glutamate release and inositol 1,4,5 trisphosphate accumulation via activation of the N-methyl d-aspartate receptor in monkey and mouse cerebral cortex slices. Adv. Enzyme Regul. 1996;36:229–244
  14. Hong CJ, Yu YW, et al. Association analysis for NMDA receptor subunit 2B (GRIN2B) genetic variants and psychopathology and clozapine response in schizophrenia. Psychiatr. Genet. 2001;11(4):219–222
  15. Ishii T, Moriyoshi K, et al. Molecular characterization of the family of the N-methyl-d-aspartate receptor subunits. J. Biol. Chem. 1993;268(4):2836–2843
  16. Jan de Beur SM, Ding CL, et al. Pseudohypoparathyroidism 1b: exclusion of parathyroid hormone and its receptors as candidate disease genes. J. Clin. Endocrinol. Metab. 2000;85(6):2239–2246
  17. Knable MB, Barci BM, et al. Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers. Mol. Psychiatry. 2002;7(4):392–404
  18. Krupp JJ, Vissel B, et al. Calcium-dependent inactivation of recombinant N-methyl-d-aspartate receptors is NR2 subunit specific. Mol. Pharmacol. 1996;50(6):1680–1688
  19. Lahiri DK, Nurnberger JI. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 1991;19(19):5444
  20. Laird NM, Horvath S, et al. Implementing a unified approach to family-based tests of association. Genet. Epidemiol. 2000;19(Suppl 1):S36–S42
  21. Laube B, Hirai H, et al. Molecular determinants of agonist discrimination by NMDA receptor subunits: analysis of the glutamate binding site on the NR2B subunit. Neuron. 1997;18(3):493–503
  22. Laurie DJ, Bartke I, et al. Regional, developmental and interspecies expression of the four NMDAR2 subunits, examined using monoclonal antibodies. Brain Res. Mol. Brain Res. 1997;51(1–2):23–32
  23. Law AJ, Deakin JF. Asymmetrical reductions of hippocampal NMDAR1 glutamate receptor mRNA in the psychoses. NeuroReport. 2001;12(13):2971–2974
  24. Lewis CM, Levinson DF, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder: Part II. Schizophrenia. Am. J. Hum. Genet. 2003;73(1):34–48
  25. Lijam N, Paylor R, et al. Social interaction and sensorimotor gating abnormalities in mice lacking Dvl1. Cell. 1997;90(5):895–905
  26. Loftis JM, Janowsky A. The N-methyl-d-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. Pharmacol. Ther. 2003;97(1):55–85
  27. Loscher W. Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action. Prog. Neurobiol. 1999;58(1):31–59
  28. Macciardi F. Multiple testing in genetic association studies: to correct or not to correct?. Am. J. Med. Genet. 2003;(122B):31–32
  29. Mandich P, Schito AM, et al. Mapping of the human NMDAR2B receptor subunit gene (GRIN2B) to chromosome 12p12. Genomics. 1994;22(1):216–218
  30. Maxwell, M.E., 1992. Family Interview for Genetic Studies. from http://www.grb.nimh.nih.gov/interviews.html.
  31. Miyatake R, Furukawa A, et al. Identification of a novel variant of the human NR2B gene promoter region and its possible association with schizophrenia. Mol. Psychiatry. 2002;7(10):1101–1106
  32. Moon IS, Apperson ML, et al. The major tyrosine-phosphorylated protein in the postsynaptic density fraction is N-methyl-d-aspartate receptor subunit 2B. Proc. Natl. Acad. Sci. U. S. A. 1994;91(9):3954–3958
  33. Mundo E, Tharmalingham S, et al. Evidence that the N-methyl-d-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder. Mol. Psychiatry. 2003;8(2):241–245
  34. Nishiguchi N, Shirakawa O, et al. Novel polymorphism in the gene region encoding the carboxyl-terminal intracellular domain of the NMDA receptor 2B subunit: analysis of association with schizophrenia. Am. J. Psychiatry. 2000;157(8):1329–1331
  35. Nonaka S, Hough CJ, et al. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-d-aspartate receptor-mediated calcium influx. Proc. Natl. Acad. Sci. U. S. A. 1998;95(5):2642–2647
  36. Ohtsuki T, Sakurai K, et al. Mutation analysis of the NMDAR2B (GRIN2B) gene in schizophrenia. Mol. Psychiatry. 2001;6(2):211–216
  37. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiatry. 1995;52(12):998–1007
  38. Owen MJ. Molecular genetic studies of schizophrenia. Brain Res. Brain Res. Rev. 2000;31(2–3):179–186
  39. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998;316(7139):1236–1238
  40. Rabinowitz D, Laird N. A unified approach to adjusting association tests for population admixture with arbitrary pedigree structure and arbitrary missing marker information. Hum. Hered. 2000;50(4):211–223
  41. Rosenberg NA, Pritchard JK, et al. Genetic structure of human populations. Science. 2002;298(5602):2381–2385
  42. Scarr E, Pavey G, et al. Decreased hippocampal NMDA, but not kainate or AMPA receptors in bipolar disorder. Bipolar Disord. 2003;5(4):257–264
  43. Schito AM, Pizzuti A, et al. mRNA distribution in adult human brain of GRIN2B, a N-methyl-d-aspartate (NMDA) receptor subunit. Neurosci. Lett. 1997;239(1):49–53
  44. Segurado R, Detera-Wadleigh SD, et al. Genome scan meta-analysis of schizophrenia and bipolar disorder: Part III. Bipolar disorder. Am. J. Hum. Genet. 2003;73(1):49–62
  45. Smart TG. Regulation of excitatory and inhibitory neurotransmitter-gated ion channels by protein phosphorylation. Curr. Opin. Neurobiol. 1997;7(3):358–367
  46. SMRI. http://www.stanleyresearch.org/programs/brain_collection.asp.
  47. Tang YP, Shimizu E, et al. Genetic enhancement of learning and memory in mice. Nature. 1999;401(6748):63–69
  48. Torrey EF, Webster M, et al. The Stanley Foundation Brain Collection and Neuropathology Consortium. Schizophr. Res. 2000;44(2):151–155
  49. Tovar KR, Sprouffske K, et al. Fast NMDA receptor-mediated synaptic currents in neurons from mice lacking the epsilon2 (NR2B) subunit. J. Neurophysiol. 2000;83(1):616–620
  50. Tsuang MT, Faraone SV, et al. Identification of the phenotype in psychiatric genetics. Eur. Arch. Psychiatry Clin. Neurosci. 1993;243(3–4):131–142
  51. Vicini S, Wang JF, et al. Functional and pharmacological differences between recombinant N-methyl-d-aspartate receptors. J. Neurophysiol. 1998;79(2):555–566
  52. Wong AH, Likhodi O, et al. Genetics and transcription of 14-3-3 isoforms in schizophrenia and bipolar disorder. Schizophr. Res. 2005;

PII: S0920-9964(06)00076-4

doi: 10.1016/j.schres.2006.02.001

Schizophrenia Research
Volume 84, Issue 2 , Pages 214-221 , June 2006

Article Tools

* Image Usage & Resolution